Wild-type p53 negatively regulates the expression of a microtubule- associated protein

Genes and Development

Volumn 10, Issue 23, 1996, Pages 2971-2980

  Murphy, Maureen ^a   Hinman, Adrian ^a   Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

apoptosis; MAP4; microtubules; p53

Indexed keywords

MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; PROTEIN P53; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANIMALIA;

EID: 0029803281     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.23.2971     Document Type: Article

References (40)

1. Ausubel, P.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1994. Current protocols in molecular biology, Vol. 2. Wiley/Greene, New York, NY.
2. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461-468.
3. Bayle, J.H., B. Elenbaas, and A.J. Levine. 1995. The carboxylterminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc. Natl. Acad. Sci. 92: 5729-5733.
4. Caelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223.
5. Chen, J., J. Lin, and A.J. Levine. 1995. Regulation of transcription functions of the p53 tumor suppressor by the mdm2 oncogene. Mol. Med. 1: 142-152.
6. Chen, J., X. Wu, J. Lin, and A.J. Levine. 1996. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16: 2445-2452.
7. Del Sal, G., M. Murphy, E.M. Ruaro, D. Lazarevic, A.J. Levine, and C. Schneider. 1996. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene 12: 177-185.
8. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
9. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
10. Frangioni, J.V. and B.G. Neel. 1993. Solubilization and purification of enzymatically active glutathione-S-transferase (pGEX) fusion proteins. Anal. Biochem. 210: 179-187.
11. Ginsberg, D., F. Mechtor, M. Yaniv, and M. Oren. 1991. Wild-type p53 can down-regulate the activity of various promoters. Proc. Natl. Acad. Sci. 88: 7605-7609.
12. Gottlieb, T.M. and M. Oren. 1996. p53 in growth control and neoplasia. Biochem. Biophys. Acta 1287: 77-102.
13. Harlow, E. and D.P. Lane. 1988. Antibodies: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
14. Haupt, Y., S. Rowan, E. Shaulian, K. Vousden, and M. Oren. 1995. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes & Dev. 9: 2170-2183.
15. Haupt, Y., Y. Barak, and M. Oren. 1996. Cell-type specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15: 1596-1606.
16. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiecstasia. Cell 71: 587-597.
17. Levine, A.J. 1993. The tumor suppressor genes. Annu. Rev. Biochem. 62: 623-651.
18. Liang, P. and A.B. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971.
19. Lin, J., J. Chen, B. Elenbaas, and A.J. Levine. 1994. Several hydrophobic ammo acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus S E1B 55-kD protein. Genes & Dev. 8: 1235-1246.
20. Maccioni, R.B. and V. Cambiazo. 1995. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev. 75: 835-864.
21. Mack, D.H., J. Vartikar, J.M. Pipas, and L. Laimins. 1993. Specific repression of TATA-mediated but not initiator-mediated transcription by wild type p53. Nature 363: 281-283.
22. Maheswaran, S., C. Englert, P. Bennet, G. Heinrich, and D.A. Haber. 1995. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes & Dev. 9: 2143-2156.
23. Martin, S.J. and T.G. Cotter. 1990. Disruption of microtubules induces an endogenous suicide pathway in human leukemia HL-60 cells. Cell Tissue Kinet. 23: 545-549.
24. Miyashita, T. and J.C. Reed. 1992. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52: 5407-5411.
25. Miyashita, T., M Harigai, M. Hanada, and J.C. Reed. 1994. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54: 3131-3135.
26. Murphy, M., M.J. Pykett, P. Hamish, K.D. Zang, and D.L. George. 1993. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Diff. 4: 715-722.
27. Olmsted, J.B. 1991. Non-motor microtubule-associated proteins. Curr. Opin. Cell Biol. 3: 52-58.
28. cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics. J. Cell. Biol. 128: 849-862.
29. Sabbatini, P., S.K. Chiou, L. Rao, and E. White. 1995a. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B-19K protein. Mol. Cell. Biol. 15: 1060-1070.
30. Sabbatini, P., J. Lin, A.J. Levine, and E. White. 1995b. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes & Dev. 9: 2184-2192.
31. Seto, E., A. Usheva, G.P. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A.J. Levine, and T. Shenk. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. 89: 12028-12032.
32. Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. 89: 4495-4499.
33. Shen, Y. and T. Shenk. 1994. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular bcl-2 protein. Proc. Natl. Acad. Sci. 91: 8940-8944.
34. cdc2 activation required for apoptosis. Science 263: 1143-1145.
35. van den Heuvel, S. and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
36. waf1/cip1. Genes & Dev. 8: 2817-2830.
37. Wyllie, A.H., J.F.R. Kerr, and A.R. Currie. 1980. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
38. Wu, X. and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Nad. Acad. Sci. 91: 3602-3606.
39. Wu, X., J.H. Bayle, D. Olson, and A.J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes & Dev. 7: 1126-1132.
40. Zhang, L., F. Kashanchi, Q. Zhan, S. Zhan, J.N. Brady, A.J. Fornace, P. Seth, and L.J. Helman. 1996. Regulation of Insulin-like growth factor II P3 promoter by p53: A potential mechanism for tumorigenesis. Cancer Res. 56: 1367-1373.